Skip to Main content Skip to Navigation
Journal articles

Plasmodium falciparum Plasmepsin 2 Duplications, West Africa

Abstract : Dihydroartemisinin/piperaquine (DHA/PPQ) is increasingly deployed as antimalaria drug in Africa. We report the detection in Mali of Plasmodium falciparum infections carrying plasmepsin 2 duplications (associated with piperaquine resistance) in 7/65 recurrent infections within 2 months after DHA/PPQ treatment. These findings raise concerns about the long-term efficacy of DHA/PPQ treatment in Africa.
Complete list of metadata

Cited literature [20 references]  Display  Hide  Download
Contributor : Christine Dupuis Connect in order to contact the contributor
Submitted on : Monday, April 8, 2019 - 4:06:33 PM
Last modification on : Tuesday, December 15, 2020 - 3:56:02 PM
Long-term archiving on: : Tuesday, July 9, 2019 - 5:14:55 PM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document




Juliana Inoue, Miguel Silva, Bakary Fofana, Kassim Sanogo, Andreas Mårtensson, et al.. Plasmodium falciparum Plasmepsin 2 Duplications, West Africa. Emerging Infectious Diseases, Centers for Disease Control and Prevention, 2018, 24 (8), pp.1591-1593. ⟨10.3201/eid2408.180370⟩. ⟨inserm-02093060⟩



Record views